|
Re: UK Govt agency (NICE--ha!)"AI+ lapatinib, AI+herceptin not cost-effective 4 Stage
Here we go again!
Just been on the national news about T-DM1. The onc estimated that it would take a further year for it to be licensed in the EU then some further period before NICE (lol) would consider its cost effectiveness! Only bit of good news was that women may be able to receive it once licensed with money from the government cancer drug fund. Will not be holding my breathe regards pertuzumab being approved anytime soon.
Ellie
|